![Phil Campbell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Phil Campbell
Corporate Officer/Principal presso Carnegie Mellon University
Profilo
Phil Campbell was the founder of Carmell Regen Med Corp.
(founded in 2007) where he held the title of Chief Scientific Officer.
He is currently working at Carnegie Mellon University as a Professor since 2013.
Posizioni attive di Phil Campbell
Società | Posizione | Inizio |
---|---|---|
Carnegie Mellon University
![]() Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | 19/08/2011 |
Precedenti posizioni note di Phil Campbell
Società | Posizione | Fine |
---|---|---|
Carmell Regen Med Corp.
![]() Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Carmell Regen Med Corp.
![]() Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Phil Campbell